Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Expert Opinion on Therapeutic Targets|November 22, 2007
Tumour targeting by microtubule-depolymerizing vascular disrupting agentsChryso Kanthou, Gillian M TozerInternational Journal of Experimental Pathology|July 1, 2009
Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologiesChryso Kanthou, Gillian M TozerBlood|March 6, 2002
The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cellsChryso Kanthou, Gillian M TozerNature Reviews. Cancer|June 2, 2005
Disrupting tumour blood vesselsGillian M Tozer, Chryso Kanthou, Bruce C BaguleyPharmaceutical Research|March 10, 2018
Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic LiposomesJasmin Monpara, Chryso Kanthou, Gillian M Tozer, et al.Journal of Cellular Biochemistry|September 24, 2002
Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapyOlga Greco, Gabi U Dachs, Gillian M Tozer, et al.International Journal of Experimental Pathology|June 13, 2002
The biology of the combretastatins as tumour vascular targeting agentsGillian M Tozer, Chryso Kanthou, Charles S Parkins, et al.Journal of Medicinal Chemistry|October 4, 2016
Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4Andrew W Brown, Matthew Fisher, Gillian M Tozer, et al.Oncotarget|December 10, 2017
The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-<i>O</i>-phosphateJoanna Shepherd, Matthew Fisher, Abigail Welford, et al.International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeabilityDorota Gabryś, Olga Greco, Gaurang Patel, et al.Pageof 7